HOME Top Market Reports Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology (ELISA, Rapid Test), Platform (Radioimmunoassay), Specimen, Application (Infectious Diseases, Oncology, Cardiology), End User (Hospitals) – Global Forecast to 2023

Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology (ELISA, Rapid Test), Platform (Radioimmunoassay), Specimen, Application (Infectious Diseases, Oncology, Cardiology), End User (Hospitals) – Global Forecast to 2023

By: marketsandmarkets.com
Publishing Date: May 2018
Report Code: MD 4751

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The immunoassays market was valued at USD 19.01 Billion in 2017 and is expected to reach USD 27.15 Billion by 2023, at a CAGR of 6.1%. The base year for this study is 2017 and the forecast period is 2018–2023.

The objectives of this study are as follows:

  • To define, describe, segment, and forecast the immunoassays market by product & service, technology, platform, specimen type, application, end user, and region
  • To forecast the revenue of the market segments of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, and opportunities affecting the growth of the market
  • To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
  • To track and analyze competitive developments such as partnerships, agreements, collaborations; mergers and acquisitions; product launches; and research and development activities in the immunoassays market

 Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product & service, technology, platform, specimen type, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources such as American Association of Immunologists (AAI), National Center for Biotechnology Information (NCBI), American Medical Association (AMA), American Autoimmune Related Diseases Association (AARDA), Association of Medical School Microbiology and Immunology Chairs (AMSMIC), Society for Immunotherapy of Cancer (SITC), Canadian Society for Immunology (CSI), German Institute of Medical Documentation and Information (DIMDI), Association of Medical Diagnostics Manufacturers (AMDM), British In Vitro Diagnostics Association (BIVDA), European Diagnostic Manufacturers Association (EDMA), Spanish Society for Immunology, British Society for Allergy & Clinical Immunology (BSACI), Chinese Society of Immunology (CSI), China Association of In-Vitro Diagnostics (CAIVD), China Association for Medical Devices Industry (CAMDI) and many others, have been used to identify and collect information useful for this extensive commercial study of the immunoassays market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information and to assess prospects of the immunoassays market. The breakdown of profiles of primaries is shown in the figure below:

Immunoassay Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the immunoassays market include Roche (Switzerland), Abbott Laboratories (US), Siemens (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), bioMιrieux (France), Ortho Clinical Diagnostics (US), DiaSorin (Italy), QIAGEN (Netherlands), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), PerkinElmer (US), Quidel Corporation (US), Bio-Techne Corporation (US), and Mindray (China).

Target Audience for this Report:

  • Manufacturers and vendors of immunoassay instruments and consumables
  • In Vitro Diagnostic (IVD) product manufacturers
  • Pharmaceutical and biopharmaceutical players
  • Diagnostic associations
  • Research associations involved in infectious and chronic diseases research
  • Various research and consulting firms
  • Distributors of immunoassays instruments and consumables
  • Contract research manufacturers of immunoassays
  • Healthcare institutions
  • Research institutes

Scope of the Report:

This report categorizes the immunoassays market into the following segments:

By Product & Service

  • Reagents & Kits
    • Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
    • Rapid Test Reagents and Kits
    • Enzyme-linked Immunospot ELISPOT Reagents and Kits
    • Western Blot Reagents and Kits
    • Other Reagents & Kits
  • Analyzers
    • By Type
      • Open-ended Systems
      • Closed-ended systems
    • By Purchase Mode
      • Rental Purchase
      • Outright Purchase
  • Software & Services

By Platform

  • Chemiluminescence Immunoassays (CLIAs)
  • Fluorescence Immunoassays (FIAs)
  • Colorimetric Immunoassays (CIs)
  • Radioimmunoassays (RIAs)
  • Other Platforms

By Technology

  • ELISA
    • First-generation
    • Second-generation
    • Third-generation
    • Fourth-generation & Above
  • Rapid Tests
  • Western Blotting
  • ELISPOT
  • Immuno-PCR
  • Other Technologies

By Specimen

  • Blood
  • Saliva
  • Urine
  • Other Specimens

By Application

  • Infectious Diseases
  • Endocrinology
  • Oncology
  • Bone & Mineral Disorders
  • Cardiology
  • Hematology & Blood Screening
  • Autoimmune Disorders
  • Toxicology
  • Neonatal Screening
  • Other Applications

By End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies & Contract Research Organizations (CROs)
  • Blood Banks
  • Research & Academic Laboratories
  • Other End Users

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Indonesia
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 24)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 28)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 36)

4 Premium Insights (Page No. - 42)
    4.1 Immunoassays: Market Overview
    4.2 Asia Pacific: Immunoassays Market, By Platform (2017)
    4.3 Immunoassays Market, By Product & Service (2018–2023)
    4.4 Geographical Snapshot of the Immunoassays Market

5 Market Overview (Page No. - 46)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Incidence of Chronic and Infectious Diseases
                               5.2.1.1.1 Increasing Use of Immunoassays in Oncology
                               5.2.1.1.2 Growing Geriatric Population
                    5.2.1.2 Technological Advancements in Immunoassay Instruments and Introduction of Novel Automated Systems
                    5.2.1.3 Growth in the Biotechnology and Biopharmaceutical Industries
                    5.2.1.4 Increasing Adoption of Immunoassay-Based Point-Of-Care Testing and Rapid Testing
                    5.2.1.5 Vital Role of Immunoassays in Drug and Alcohol Testing
                               5.2.1.5.1 Growing Drug and Alcohol Consumption
                               5.2.1.5.2 Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
           5.2.2 Restraints
                    5.2.2.1 Stringent Regulatory Requirements for the Approval of Immunoassay Instruments and Consumables
                    5.2.2.2 Implementation of Excise Duty on the Sale of Medical Devices in the US
                    5.2.2.3 Unfavorable Reimbursement Scenario
           5.2.3 Opportunities
                    5.2.3.1 Growth Opportunities in Emerging Economies
                    5.2.3.2 Increasing Importance of Companion Diagnostics in the Immunoassays Market
                    5.2.3.3 Development of Condition-Specific Biomarkers and Tests
                    5.2.3.4 Integration of Microfluidics Technology in Immunoassays
           5.2.4 Challenges
                    5.2.4.1 Complexities in Conducting Diagnostic Tests

6 Immunoassays Market, By Product & Service (Page No. - 60)
    6.1 Introduction
    6.2 Reagents & Kits
           6.2.1 Reagents & Kits Market, By Type
                    6.2.1.1 Elisa Reagents & Kits
                    6.2.1.2 Rapid Test Reagents & Kits
                    6.2.1.3 Elispot Reagents & Kits
                    6.2.1.4 Western Blot Reagents & Kits
                    6.2.1.5 Other Reagents & Kits
    6.3 Analyzers
           6.3.1 Immunoassay Analyzers Market, By Type
                    6.3.1.1 Open-Ended Systems
                    6.3.1.2 Closed-Ended Systems
           6.3.2 Immunoassay Analyzers Market, By Purchase Mode
                    6.3.2.1 Rental Purchase
                    6.3.2.2 Outright Purchase
    6.4 Software & Services

7 Immunoassays Market, By Platform (Page No. - 77)
    7.1 Introduction
    7.2 Chemiluminescence Immunoassays
    7.3 Fluorescence Immunoassays
    7.4 Colorimetric Immunoassays
    7.5 Radioimmunoassays
    7.6 Other Platforms

8 Immunoassays Market, By Technology (Page No. - 85)
    8.1 Introduction
    8.2 Enzyme-Linked Immunosorbent Assays
           8.2.1 Elisa Market, By Generation
                    8.2.1.1 First-Generation Elisa
                    8.2.1.2 Second-Generation Elisa
                    8.2.1.3 Third-Generation Elisa
                    8.2.1.4 Fourth-Generation & Above Elisa
    8.3 Rapid Tests
    8.4 Enzyme-Linked Immunospot
    8.5 Western Blotting
    8.6 Immuno-PCR
    8.7 Other Technologies

9 Immunoassays Market, By Specimen Type (Page No. - 101)
    9.1 Introduction
    9.2 Blood
    9.3 Saliva
    9.4 Urine
    9.5 Other Specimens

10 Immunoassays Market, By Application (Page No. - 107)
     10.1 Introduction
     10.2 Infectious Diseases
     10.3 Endocrinology
     10.4 Oncology
     10.5 Bone & Mineral Disorders
     10.6 Cardiology
     10.7 Hematology & Blood Screening
     10.8 Autoimmune Disorders
     10.9 Toxicology
     10.10 Neonatal Screening
     10.11 Other Applications

11 Immunoassays Market, By End User (Page No. - 122)
     11.1 Introduction
     11.2 Hospitals
     11.3 Clinical Laboratories
     11.4 Pharmaceutical and Biotechnology Companies & Cros
     11.5 Blood Banks
     11.6 Research & Academic Laboratories
     11.7 Other End Users

12 Global Immunoassays Market, By Region (Page No. - 132)
     12.1 Introduction
     12.2 North America
             12.2.1 US
             12.2.2 Canada
             12.2.3 Mexico
     12.3 Europe
             12.3.1 Germany
             12.3.2 Italy
             12.3.3 France
             12.3.4 Spain
             12.3.5 UK
             12.3.6 Russia
             12.3.7 Rest of Europe
     12.4 Asia Pacific
             12.4.1 Japan
             12.4.2 China
             12.4.3 India
             12.4.4 Australia
             12.4.5 South Korea
             12.4.6 Indonesia
             12.4.7 Rest of Asia Pacific
     12.5 Latin America
     12.6 Middle East & Africa

13 Competitive Landscape (Page No. - 270)
     13.1 Overview
     13.2 Market Share Analysis
     13.3 Competitive Situation and Trends
             13.3.1 Product Launches
             13.3.2 Partnerships, Collaborations, and Agreements
             13.3.3 Expansions
             13.3.4 Acquisitions

14 Company Profiles (Page No. - 275)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     14.1 Roche
     14.2 Abbott Laboratories
     14.3 Siemens
     14.4 Danaher
     14.5 DiaSorin
     14.6 Sysmex
     14.7 BioMιrieux
     14.8 Ortho Clinical Diagnostics
     14.9 QIAGEN
     14.10 Thermo Fisher Scientific
     14.11 Becton, Dickinson & Company
     14.12 Bio-Rad Laboratories
     14.13 Agilent Technologies
     14.14 Mindray
     14.15 Perkinelmer
     14.16 Quidel
     14.17 Merck
     14.18 Bio-Techne

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. - 334)
     15.1 Industry Insights
     15.2 Discussion Guide
     15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     15.4 Introducing RT: Real-Time Market Intelligence
     15.5 Available Customizations
     15.6 Related Reports
     15.7 Author Details


List of Tables (293 Tables)

Table 1 Global Incidence of Infectious Diseases in 2015
Table 2 Global Incidence of the Top 10 Cancers (2012, 2015, & 2035)
Table 3 Detection of Drugs By Urine Testing
Table 4 New Tests Launched By Key Players
Table 5 Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 6 Immunoassay Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 7 Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 8 Elisa Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 9 Rapid Test Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 10 Elispot Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 11 Western Blot Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 12 Other Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 13 Immunoassay Analyzers Market, By Region, 2016–2023 (USD Million)
Table 14 Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 15 Open-Ended Systems Market, By Region, 2016–2023 (USD Million)
Table 16 Closed-Ended Systems Market, By Region, 2016–2023 (USD Million)
Table 17 Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 18 Immunoassay Analyzers Rental Purchase Market, By Region, 2016–2023 (USD Million)
Table 19 Immunoassay Analyzers Outright Purchase Market, By Region, 2016–2023 (USD Million)
Table 20 Immunoassay Software & Services Market, By Region, 2016–2023 (USD Million)
Table 21 Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 22 Clia Systems Available in the Market
Table 23 Chemiluminescence Immunoassays Market, By Region, 2016–2023 (USD Million)
Table 24 Fluorescence Immunoassays Market, By Region, 2016–2023 (USD Million)
Table 25 Colorimetric Immunoassays Market, By Region, 2016–2023 (USD Million)
Table 26 Radioimmunoassays Market, By Region, 2016–2023 (USD Million)
Table 27 Other Platforms Market, By Region, 2016–2023 (USD Million)
Table 28 Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 29 Key Elisa Systems Available in the Market
Table 30 Elisa Market, By Region, 2016–2023 (USD Million)
Table 31 Elisa Market, By Generation, 2016–2023 (USD Million)
Table 32 First-Generation Elisa Market, By Region, 2016–2023 (USD Million)
Table 33 Second-Generation Elisa Market, By Region, 2016–2023 (USD Million)
Table 34 Third-Generation Elisa Market, By Region, 2016–2023 (USD Million)
Table 35 Fourth-Generation & Above Elisa Market, By Region, 2016–2023 (USD Million)
Table 36 Key Rapid Tests Available in the Market
Table 37 Rapid Tests Market, By Region, 2016–2023 (USD Million)
Table 38 Elispot Market, By Region, 2016–2023 (USD Million)
Table 39 Western Blotting Systems Available in the Market
Table 40 Western Blotting Market, By Region, 2016–2023 (USD Million)
Table 41 Immuno-PCR Market, By Region, 2016–2023 (USD Million)
Table 42 Other Immunoassay Technologies Market, By Region, 2016–2023 (USD Million)
Table 43 Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 44 Immunoassays Market for Blood Samples, By Region, 2016–2023 (USD Million)
Table 45 Immunoassays Market for Saliva Samples, By Region, 2016–2023 (USD Million)
Table 46 Immunoassays Market for Urine Samples, By Region, 2016–2023 (USD Million)
Table 47 Immunoassays Market for Other Specimens, By Region, 2016–2023 (USD Million)
Table 48 Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 49 Immunoassays Market for Infectious Diseases, By Region, 2016–2023 (USD Million)
Table 50 Immunoassays Market for Endocrinology, By Region, 2016–2023 (USD Million)
Table 51 Immunoassays Market for Oncology, By Region, 2016–2023 (USD Million)
Table 52 Immunoassays Market for Bone & Mineral Disorders, By Region, 2016–2023 (USD Million)
Table 53 Immunoassays Market for Cardiology, By Region, 2016–2023 (USD Million)
Table 54 Immunoassays Market for Hematology & Blood Screening, By Region, 2016–2023 (USD Million)
Table 55 Immunoassays Market for Autoimmune Disorders, By Region, 2016–2023 (USD Million)
Table 56 Immunoassays Market for Toxicology, By Region, 2016–2023 (USD Million)
Table 57 Immunoassays Market for Neonatal Screening, By Region, 2016–2023 (USD Million)
Table 58 Immunoassays Market for Other Applications, By Region, 2016–2023 (USD Million)
Table 59 Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 60 Immunoassays Market for Hospitals, By Region, 2016–2023 (USD Million)
Table 61 Immunoassays Market for Clinical Laboratories, By Region, 2016–2023 (USD Million)
Table 62 Immunoassays Market for Pharmaceutical and Biotechnology Companies and Cros, By Region, 2016–2023 (USD Million)
Table 63 Immunoassays Market for Blood Banks, By Region, 2016–2023 (USD Million)
Table 64 Immunoassays Market for Research & Academic Laboratories, By Region, 2016–2023 (USD Million)
Table 65 Immunoassays Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 66 Immunoassays Market, By Region, 2016–2023 (USD Million)
Table 67 North America: Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 68 North America: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 69 North America: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 70 North America: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 71 North America: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 72 North America: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 73 North America: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 74 North America: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 75 North America: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 76 North America: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 77 North America: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 78 US: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 79 US: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 80 US: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 81 US: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 82 US: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 83 US: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 84 US: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 85 US: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 86 US: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 87 US: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 88 Canada: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 89 Canada: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 90 Canada: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 91 Canada: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 92 Canada: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 93 Canada: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 94 Canada: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 95 Canada: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 96 Canada: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 97 Canada: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 98 Mexico: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 99 Mexico: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 100 Mexico: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 101 Mexico: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 102 Mexico: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 103 Mexico: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 104 Mexico: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 105 Mexico: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 106 Mexico: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 107 Mexico: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 108 Europe: Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 109 Europe: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 110 Europe: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 111 Europe: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 112 Europe: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 113 Europe: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 114 Europe: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 115 Europe: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 116 Europe: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 117 Europe: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 118 Europe: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 119 Germany: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 120 Germany: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 121 Germany: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 122 Germany: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 123 Germany: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 124 Germany: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 125 Germany: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 126 Germany: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 127 Germany: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 128 Germany: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 129 Italy: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 130 Italy: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 131 Italy: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 132 Italy: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 133 Italy: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 134 Italy: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 135 Italy: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 136 Italy: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 137 Italy: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 138 Italy: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 139 France: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 140 France: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 141 France: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 142 France: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 143 France: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 144 France: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 145 France: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 146 France: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 147 France: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 148 France: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 149 Spain: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 150 Spain: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 151 Spain: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 152 Spain: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 153 Spain: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 154 Spain: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 155 Spain: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 156 Spain: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 157 Spain: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 158 Spain: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 159 UK: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 160 UK: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 161 UK: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 162 UK: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 163 UK: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 164 UK: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 165 UK: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 166 UK: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 167 UK: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 168 UK: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 169 Russia: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 170 Russia: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 171 Russia: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 172 Russia: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 173 Russia: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 174 Russia: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 175 Russia: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 176 Russia: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 177 Russia: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 178 Russia: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 179 RoE: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 180 RoE: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 181 RoE: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 182 RoE: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 183 RoE: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 184 RoE: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 185 RoE: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 186 RoE: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 187 RoE: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 188 RoE: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 189 Asia Pacific: Immunoassays Market, By Country, 2016–2023 (USD Million)
Table 190 Asia Pacific: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 191 Asia Pacific: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 192 Asia Pacific: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 193 Asia Pacific: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 194 Asia Pacific: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 195 Asia Pacific: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 196 Asia Pacific: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 197 Asia Pacific: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 198 Asia Pacific: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 199 Asia Pacific: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 200 Japan: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 201 Japan: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 202 Japan: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 203 Japan: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 204 Japan: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 205 Japan: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 206 Japan: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 207 Japan: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 208 Japan: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 209 Japan: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 210 China: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 211 China: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 212 China: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 213 China: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 214 China: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 215 China: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 216 China: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 217 China: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 218 China: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 219 China: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 220 India: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 221 India: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 222 India: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 223 India: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 224 India: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 225 India: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 226 India: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 227 India: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 228 India: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 229 India: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 230 Australia: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 231 Australia: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 232 Australia: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 233 Australia: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 234 Australia: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 235 Australia: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 236 Australia: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 237 Australia: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 238 Australia: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 239 Australia: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 240 South Korea: Immunoassays Market, By Product & Service,  2016–2023 (USD Million)
Table 241 South Korea: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 242 South Korea: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 243 South Korea: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 244 South Korea: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 245 South Korea: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 246 South Korea: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 247 South Korea: Immunoassays Market, By Specimen Type,  2016–2023 (USD Million)
Table 248 South Korea: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 249 South Korea: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 250 Indonesia: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 251 Indonesia: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 252 Indonesia: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 253 Indonesia: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 254 Indonesia: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 255 Indonesia: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 256 Indonesia: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 257 Indonesia: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 258 Indonesia: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 259 Indonesia: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 260 RoAPAC: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 261 RoAPAC: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 262 RoAPAC: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 263 RoAPAC: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 264 RoAPAC: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 265 RoAPAC: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 266 RoAPAC: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 267 RoAPAC: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 268 RoAPAC: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 269 RoAPAC: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 270 Latin America: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 271 Latin America: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 272 Latin America: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 273 Latin America: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 274 Latin America: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 275 Latin America: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 276 Latin America: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 277 Latin America: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 278 Latin America: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 279 Latin America: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 280 MEA: Immunoassays Market, By Product & Service, 2016–2023 (USD Million)
Table 281 MEA: Immunoassay Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 282 MEA: Immunoassay Analyzers Market, By Type, 2016–2023 (USD Million)
Table 283 MEA: Immunoassay Analyzers Market, By Purchase Mode, 2016–2023 (USD Million)
Table 284 MEA: Immunoassays Market, By Technology, 2016–2023 (USD Million)
Table 285 MEA: Elisa Market, By Generation, 2016–2023 (USD Million)
Table 286 MEA: Immunoassays Market, By Platform, 2016–2023 (USD Million)
Table 287 MEA: Immunoassays Market, By Specimen Type, 2016–2023 (USD Million)
Table 288 MEA: Immunoassays Market, By Application, 2016–2023 (USD Million)
Table 289 MEA: Immunoassays Market, By End User, 2016–2023 (USD Million)
Table 290 Product Launches, 2014–2017
Table 291 Partnerships, Collaborations, and Agreements, 2014–2017
Table 292 Expansions, 2014–2017
Table 293 Acquisitions, 2014–2017
 
 
List of Figures (50 Figures)
 
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Immunoassays Market, By Product & Service, 2018 vs 2023 (USD Billion)
Figure 7 Immunoassays Market, By Platform, 2018 vs 2023 (USD Billion)
Figure 8 Immunoassays Market, By Technology, 2018 vs 2023 (USD Billion)
Figure 9 Immunoassays Market, By Specimen Type, 2018 vs 2023 (USD Billion)
Figure 10 Immunoassays Market, By Application, 2018 vs 2023 (USD Billion)
Figure 11 Immunoassays Market, By End User, 2018 vs 2023 (USD Billion)
Figure 12 Immunoassays Market, By Region, 2018 vs 2023 (USD Billion)
Figure 13 Increasing Incidence of Chronic & Infectious Diseases and Technological Advancements in Immunoassay Instruments to Drive Market Growth During the Forecast Period
Figure 14 Chemiluminescence Immunoassays Accounted for the Largest Share of the Asia Pacific Immunoassays Market in 2017
Figure 15 Software & Services to Register the Highest Growth Rate During the Forecast Period
Figure 16 China & India to Witness the Highest Growth Rates in the Immunoassays Market From 2018 to 2023
Figure 17 Immunoassays Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Global Incidence of Diabetes, By Region, 2017 vs 2045
Figure 19 Global Aging Population, By Region, 2017 vs 2050 (Million)
Figure 20 Immunoassay Reagents & Kits Segment to Dominate the Market During the Forecast Period
Figure 21 Elisa Reagents & Kits Segment to Dominate the Immunoassay Reagents & Kits Market During the Forecast Period
Figure 22 Open-Ended Systems Segment to Dominate the Immunoassay Analyzers Market, By Type, During the Forecast Period
Figure 23 Rental Purchase Segment to Dominate the Immunoassay Analyzers Market, By Purchase Mode, During the Forecast Period
Figure 24 Chemiluminescence Immunoassays to Dominate the Market During the Forecast Period
Figure 25 Elisa Segment to Dominate the Market During the Forecast Period
Figure 26 Fourth-Generation & Above Elisa Segment to Dominate the Market During the Forecast Period
Figure 27 Blood Samples Segment to Dominate the Immunoassays Market, By Specimen Type, During the Forecast Period
Figure 28 Infectious Diseases Segment to Dominate the Market During the Forecast Period
Figure 29 Number of People Living With Hiv Globally, 2010 - 2016
Figure 30 Hospitals Segment to Dominate the Immunoassays Market in 2023
Figure 31 North America to Dominate the Global Immunoassays Market in 2018
Figure 32 North America: Immunoassays Market Snapshot
Figure 33 Asia Pacific: Immunoassays Market Snapshot
Figure 34 Market Share Analysis – 2017
Figure 35 Roche: Company Snapshot (2017)
Figure 36 Abbott Laboratories: Company Snapshot (2017)
Figure 37 Siemens: Company Snapshot (2017)
Figure 38 Danaher: Company Snapshot (2017)
Figure 39 DiaSorin: Company Snapshot (2016)
Figure 40 Sysmex: Company Snapshot (2017)
Figure 41 BioMιrieux: Company Snapshot (2016)
Figure 42 QIAGEN: Company Snapshot (2016)
Figure 43 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 44 BD: Company Snapshot (2017)
Figure 45 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 46 Agilent Technologies: Company Snapshot (2017)
Figure 47 Perkinelmer: Company Snapshot (2017)
Figure 48 Quidel: Company Snapshot (2016)
Figure 49 Merck: Company Snapshot (2016)
Figure 50 Bio-Techne: Company Snapshot (2017)

The global immunoassays market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The market growth is primarily driven by the increasing incidence of chronic and infectious diseases and technological innovations in immunoassays instruments.

The global immunoassays market is segmented by product and service, platform, technology, specimen type, application, end user, and region. By product and service, the market is segmented into reagents and kits, analyzers, and software & services. The immunoassay reagents and kits segment accounted for the largest share of this market in 2017. The large share of this segment can primarily be attributed to the requirement of the repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases.

By platform, the market is segmented into chemiluminescence immunoassays (CLIAs), colorimetric immunoassays (CIs), fluorescence immunoassays (FIAs), radioimmunoassays (RIAs), and other platforms. The CLIAs segment accounted for the largest share of the immunoassays market in 2017. The large share of this segment can primarily be attributed to the low cost and high sensitivity of CLIA-based tests.

On the basis of technology, the immunoassays market is segmented into enzyme-linked immunosorbent assays (ELISA), rapid tests, western blotting, enzyme-linked immunospot (ELISPOT), immuno-PCR, and other technologies. The ELISA segment accounted for the largest share of the immunoassays market in 2017. The large share of this segment can primarily be attributed to the increasing use of immunoassay tests in cancer, infectious diseases, and therapeutic drug level monitoring.

By specimen type, the immunoassays market is segmented into blood, urine, saliva, and other specimens. In 2017, the blood samples segment accounted for the largest share of the immunoassays market. Moreover, this segment is projected to register the highest CAGR during the forecast period, primarily due to the increasing number of blood donations and the rising incidence of chronic and infectious diseases across the globe.

By application, the immunoassays market is classified into infectious diseases, endocrinology, bone and mineral disorders, oncology, cardiology, hematology and blood screening, autoimmune disorders, toxicology, neonatal screening, and other applications. In 2017, the infectious diseases segment accounted for the largest share of the immunoassays market. The large share of this segment can be attributed to the increasing incidence of infectious diseases and the rising number of product approvals in this segment.

On the basis of end users, the immunoassays market is segmented into hospitals, clinical laboratories, blood banks, research and academic laboratories, pharmaceutical and biotechnology companies and contract research organizations (CROs), and other end users. The hospitals segment accounted for the largest share of the immunoassays market in 2017. The large share of this segment is primarily attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories due to easy access to reports and smooth logistics. Additionally, these laboratories also work as reference laboratories to small hospitals and physician offices.

Immunoassay Market

On the basis of region, the immunoassays market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, North America accounted for the largest share of the immunoassays market. The availability of government funds, growing use of immunoassays in clinical diagnostics, and the presence of key players in the region are driving the immunoassays market in North America.

The factors such as the high degree of consolidation and a complex regulatory framework for the approval of new products may restrain market growth to a certain extent.

Major industry players adopted product launches and partnerships, collaborations, & agreements to maintain and improve their position in the immunoassays market. Roche (Switzerland), Abbott Laboratories (US), Siemens (Germany), and Danaher Corporation (US) have been identified as key players in this market. These companies have a broad product portfolio with comprehensive features and have also expanded their presence geographically. These leaders also have products for all end users in this market, a strong geographical presence, and they focus on continuous product innovations.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement


-
Request for FREE Sample of this report Send Request